Last 12 months
Inside the activity.
0 purchase rows · 57 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 4 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 33 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 02, 2026 Filed Jul 7, 2026 20:47 UTC |
Kapusta Matthew CDirector · CEO, Managing Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 21,082 | $0.00 Strike: $19.39 | $0.00 |
DisclosureSEC source: 0000904454-26-000397 · edgar.xml · derivative · entry 5 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 21,082 shares Expires 2028-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F5 · derivative.exercise_date: The Stock Option vested in full on January 26, 2022. Read SEC document |
| July 02, 2026 Filed Jul 7, 2026 20:47 UTC |
Kapusta Matthew CDirector · CEO, Managing Director
|
SaleOrdinary Shares | 7,600 | $45.89 | $348,764.00 |
DisclosureSEC source: 0000904454-26-000397 · edgar.xml · nonDerivative · entry 4 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 519,227 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.48 to $46.10. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 02, 2026 Filed Jul 7, 2026 20:47 UTC |
Kapusta Matthew CDirector · CEO, Managing Director
|
SaleOrdinary Shares | 4,282 | $45.43 | $194,531.26 |
DisclosureSEC source: 0000904454-26-000397 · edgar.xml · nonDerivative · entry 3 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 526,827 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.95. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 02, 2026 Filed Jul 7, 2026 20:47 UTC |
Kapusta Matthew CDirector · CEO, Managing Director
|
SaleOrdinary Shares | 9,200 | $44.43 | $408,756.00 |
DisclosureSEC source: 0000904454-26-000397 · edgar.xml · nonDerivative · entry 2 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 531,109 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $44.10 to $44.80. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 02, 2026 Filed Jul 7, 2026 20:47 UTC |
Kapusta Matthew CDirector · CEO, Managing Director
|
Exercise / conversionOrdinary Shares | 21,082 | $19.39 | $408,779.98 |
DisclosureSEC source: 0000904454-26-000397 · edgar.xml · nonDerivative · entry 1 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 540,309 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 20:54 UTC |
Kaye JackDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 17,060 | $0.00 Strike: $20.18 | $0.00 |
DisclosureSEC source: 0000904454-26-000392 · edgar.xml · derivative · entry 6 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 17,060 shares Expires 2033-06-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on June 16, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F5 · derivative.exercise_date: The Stock Option vested in full on June 13, 2024. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 20:54 UTC |
Kaye JackDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,107 | $0.00 Strike: $37.00 | $0.00 |
DisclosureSEC source: 0000904454-26-000392 · edgar.xml · derivative · entry 5 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 4,107 shares Expires 2031-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on June 16, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F4 · derivative.exercise_date: The Stock Option vested in full on February 25, 2022. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 20:54 UTC |
Kaye JackDirector
|
SaleOrdinary Shares | 17,060 | $46.43 | $792,095.80 |
DisclosureSEC source: 0000904454-26-000392 · edgar.xml · nonDerivative · entry 4 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,996 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on June 16, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.19 to $46.80. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 20:54 UTC |
Kaye JackDirector
|
Exercise / conversionOrdinary Shares | 17,060 | $20.18 | $344,270.80 |
DisclosureSEC source: 0000904454-26-000392 · edgar.xml · nonDerivative · entry 3 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,056 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on June 16, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 20:54 UTC |
Kaye JackDirector
|
SaleOrdinary Shares | 4,107 | $46.49 | $190,934.43 |
DisclosureSEC source: 0000904454-26-000392 · edgar.xml · nonDerivative · entry 2 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,996 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on June 16, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.19 to $46.88. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 20:54 UTC |
Kaye JackDirector
|
Exercise / conversionOrdinary Shares | 4,107 | $37.00 | $151,959.00 |
DisclosureSEC source: 0000904454-26-000392 · edgar.xml · nonDerivative · entry 1 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,103 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on June 16, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 20:59 UTC |
Abi-Saab WalidChief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $5.59 | $0.00 |
DisclosureSEC source: 0000904454-26-000394 · edgar.xml · derivative · entry 4 Abi-Saab Walid · CIK 0001985973 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 50,500 Underlying: Ordinary Shares · 10,000 shares Expires 2034-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on September 26, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F4 · derivative.exercise_date: The Stock Option was granted on March 1, 2024 and vested 25% on the first anniversary of the date of grant, and vests 6.25% quarterly thereafter until fully vested. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 20:59 UTC |
Abi-Saab WalidChief Medical Officer
|
SaleOrdinary Shares | 20,000 | $46.40 | $928,000.00 |
DisclosureSEC source: 0000904454-26-000394 · edgar.xml · nonDerivative · entry 3 Abi-Saab Walid · CIK 0001985973 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 148,235 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on September 26, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.24 to $46.80. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 20:59 UTC |
Abi-Saab WalidChief Medical Officer
|
SaleOrdinary Shares | 10,000 | $46.46 | $464,600.00 |
DisclosureSEC source: 0000904454-26-000394 · edgar.xml · nonDerivative · entry 2 Abi-Saab Walid · CIK 0001985973 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 168,235 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on September 26, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.19 to $46.97. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 20:59 UTC |
Abi-Saab WalidChief Medical Officer
|
Exercise / conversionOrdinary Shares | 10,000 | $5.59 | $55,900.00 |
DisclosureSEC source: 0000904454-26-000394 · edgar.xml · nonDerivative · entry 1 Abi-Saab Walid · CIK 0001985973 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 178,235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on September 26, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| June 26, 2026 Filed Jun 30, 2026 21:06 UTC |
Abi-Saab WalidChief Medical Officer
|
SaleOrdinary Shares | 1,434 | $46.86 | $67,197.24 |
DisclosureSEC source: 0000904454-26-000387 · edgar.xml · nonDerivative · entry 1 Abi-Saab Walid · CIK 0001985973 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 168,235 F1 · kind: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F1 · shares: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.69 to $46.96. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 25, 2026 Filed Jun 26, 2026 21:15 UTC |
Kapusta Matthew CDirector · CEO, Managing Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 28,716 | $0.00 Strike: $31.71 | $0.00 |
DisclosureSEC source: 0000904454-26-000375 · edgar.xml · derivative · entry 6 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 45,862 Underlying: Ordinary Shares · 28,716 shares Expires 2029-01-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · derivative.exercise_date: The Stock Option vested in full on January 25, 2023. Read SEC document |
| June 25, 2026 Filed Jun 26, 2026 21:15 UTC |
Kapusta Matthew CDirector · CEO, Managing Director
|
SaleOrdinary Shares | 28,716 | $50.02 | $1,436,374.32 |
DisclosureSEC source: 0000904454-26-000375 · edgar.xml · nonDerivative · entry 4 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 519,227 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.30. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 25, 2026 Filed Jun 26, 2026 21:15 UTC |
Kapusta Matthew CDirector · CEO, Managing Director
|
Exercise / conversionOrdinary Shares | 28,716 | $31.71 | $910,584.36 |
DisclosureSEC source: 0000904454-26-000375 · edgar.xml · nonDerivative · entry 3 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 547,943 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| June 24, 2026 Filed Jun 26, 2026 21:15 UTC |
Kapusta Matthew CDirector · CEO, Managing Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,128 | $0.00 Strike: $31.71 | $0.00 |
DisclosureSEC source: 0000904454-26-000375 · edgar.xml · derivative · entry 5 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 74,578 Underlying: Ordinary Shares · 4,128 shares Expires 2029-01-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · derivative.exercise_date: The Stock Option vested in full on January 25, 2023. Read SEC document |
| June 24, 2026 Filed Jun 26, 2026 21:15 UTC |
Kapusta Matthew CDirector · CEO, Managing Director
|
SaleOrdinary Shares | 6,696 | $50.00 | $334,800.00 |
DisclosureSEC source: 0000904454-26-000375 · edgar.xml · nonDerivative · entry 2 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 519,227 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| June 24, 2026 Filed Jun 26, 2026 21:15 UTC |
Kapusta Matthew CDirector · CEO, Managing Director
|
Exercise / conversionOrdinary Shares | 4,128 | $31.71 | $130,898.88 |
DisclosureSEC source: 0000904454-26-000375 · edgar.xml · nonDerivative · entry 1 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 525,923 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| June 18, 2026 Filed Jun 22, 2026 12:31 UTC |
Kapusta Matthew CDirector · CEO, Managing Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,656 | $0.00 Strike: $31.71 | $0.00 |
DisclosureSEC source: 0000904454-26-000372 · edgar.xml · derivative · entry 12 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 78,706 Underlying: Ordinary Shares · 4,656 shares Expires 2029-01-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F9 · derivative.exercise_date: The Stock Option vested in full on January 25, 2023. Read SEC document |
| June 18, 2026 Filed Jun 22, 2026 12:31 UTC |
Kapusta Matthew CDirector · CEO, Managing Director
|
SaleOrdinary Shares | 37,015 | $50.00 | $1,850,750.00 |
DisclosureSEC source: 0000904454-26-000372 · edgar.xml · nonDerivative · entry 10 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 521,795 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.01. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 18, 2026 Filed Jun 22, 2026 12:31 UTC |
Kapusta Matthew CDirector · CEO, Managing Director
|
SaleOrdinary Shares | 4,656 | $50.00 | $232,800.00 |
DisclosureSEC source: 0000904454-26-000372 · edgar.xml · nonDerivative · entry 9 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 558,810 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.00 to $50.03. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 18, 2026 Filed Jun 22, 2026 12:31 UTC |
Kapusta Matthew CDirector · CEO, Managing Director
|
Exercise / conversionOrdinary Shares | 4,656 | $31.71 | $147,641.76 |
DisclosureSEC source: 0000904454-26-000372 · edgar.xml · nonDerivative · entry 8 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 563,466 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 11:54 UTC |
Kaye JackDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,295 | $0.00 Strike: $31.71 | $0.00 |
DisclosureSEC source: 0000904454-26-000368 · edgar.xml · derivative · entry 3 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 5,295 shares Expires 2029-01-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on June 16, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · derivative.exercise_date: The Stock Option vested in full on January 25, 2020. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 11:54 UTC |
Kaye JackDirector
|
SaleOrdinary Shares | 5,295 | $42.57 | $225,408.15 |
DisclosureSEC source: 0000904454-26-000368 · edgar.xml · nonDerivative · entry 2 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,996 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on June 16, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.50 to $42.83. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 11:54 UTC |
Kaye JackDirector
|
Exercise / conversionOrdinary Shares | 5,295 | $31.71 | $167,904.45 |
DisclosureSEC source: 0000904454-26-000368 · edgar.xml · nonDerivative · entry 1 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,291 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on June 16, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 12:31 UTC |
Kapusta Matthew CDirector · CEO, Managing Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 62,581 | $0.00 Strike: $19.39 | $0.00 |
DisclosureSEC source: 0000904454-26-000372 · edgar.xml · derivative · entry 11 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,082 Underlying: Ordinary Shares · 62,581 shares Expires 2028-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F8 · derivative.exercise_date: The Stock Option vested in full on January 26, 2022. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 12:31 UTC |
Kapusta Matthew CDirector · CEO, Managing Director
|
SaleOrdinary Shares | 11,585 | $48.65 | $563,610.25 |
DisclosureSEC source: 0000904454-26-000372 · edgar.xml · nonDerivative · entry 7 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 558,810 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 12:31 UTC |
Kapusta Matthew CDirector · CEO, Managing Director
|
SaleOrdinary Shares | 33,334 | $45.01 | $1,500,363.34 |
DisclosureSEC source: 0000904454-26-000372 · edgar.xml · nonDerivative · entry 6 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 570,395 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.17. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 12:31 UTC |
Kapusta Matthew CDirector · CEO, Managing Director
|
SaleOrdinary Shares | 56,929 | $43.43 | $2,472,426.47 |
DisclosureSEC source: 0000904454-26-000372 · edgar.xml · nonDerivative · entry 5 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 603,729 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 12:31 UTC |
Kapusta Matthew CDirector · CEO, Managing Director
|
SaleOrdinary Shares | 32,581 | $45.02 | $1,466,796.62 |
DisclosureSEC source: 0000904454-26-000372 · edgar.xml · nonDerivative · entry 4 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 660,658 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.02. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 12:31 UTC |
Kapusta Matthew CDirector · CEO, Managing Director
|
SaleOrdinary Shares | 6,023 | $43.70 | $263,205.10 |
DisclosureSEC source: 0000904454-26-000372 · edgar.xml · nonDerivative · entry 3 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 693,239 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $43.56 to $43.94. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 12:31 UTC |
Kapusta Matthew CDirector · CEO, Managing Director
|
SaleOrdinary Shares | 23,977 | $42.61 | $1,021,659.97 |
DisclosureSEC source: 0000904454-26-000372 · edgar.xml · nonDerivative · entry 2 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 699,262 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.50 to $43.48. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 12:31 UTC |
Kapusta Matthew CDirector · CEO, Managing Director
|
Exercise / conversionOrdinary Shares | 62,581 | $19.39 | $1,213,445.59 |
DisclosureSEC source: 0000904454-26-000372 · edgar.xml · nonDerivative · entry 1 Kapusta Matthew C · CIK 0001536290 · Director · CEO, Managing Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 723,239 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on October 5, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 12:05 UTC |
Balachandran MadhavanDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,390 | $0.00 Strike: $19.39 | $0.00 |
DisclosureSEC source: 0000904454-26-000370 · edgar.xml · derivative · entry 7 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 6,390 shares Expires 2028-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on March 10, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F6 · derivative.exercise_date: The Stock Option vested in full on January 26, 2019. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 12:05 UTC |
Balachandran MadhavanDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,295 | $0.00 Strike: $31.71 | $0.00 |
DisclosureSEC source: 0000904454-26-000370 · edgar.xml · derivative · entry 6 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 5,295 shares Expires 2029-01-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on March 10, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F5 · derivative.exercise_date: The Stock Option vested in full on January 25, 2020. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 12:05 UTC |
Balachandran MadhavanDirector
|
SaleOrdinary Shares | 1,690 | $42.60 | $71,994.00 |
DisclosureSEC source: 0000904454-26-000370 · edgar.xml · nonDerivative · entry 5 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,254 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on March 10, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.50 to $42.93. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 12:05 UTC |
Balachandran MadhavanDirector
|
SaleOrdinary Shares | 4,700 | $43.66 | $205,202.00 |
DisclosureSEC source: 0000904454-26-000370 · edgar.xml · nonDerivative · entry 4 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,944 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on March 10, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $43.12 to $43.95. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 12:05 UTC |
Balachandran MadhavanDirector
|
SaleOrdinary Shares | 5,295 | $47.08 | $249,288.60 |
DisclosureSEC source: 0000904454-26-000370 · edgar.xml · nonDerivative · entry 3 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 49,644 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on March 10, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $47.00 to $47.36. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 12:05 UTC |
Balachandran MadhavanDirector
|
Exercise / conversionOrdinary Shares | 6,390 | $19.39 | $123,902.10 |
DisclosureSEC source: 0000904454-26-000370 · edgar.xml · nonDerivative · entry 2 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,939 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on March 10, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 12:05 UTC |
Balachandran MadhavanDirector
|
Exercise / conversionOrdinary Shares | 5,295 | $31.71 | $167,904.45 |
DisclosureSEC source: 0000904454-26-000370 · edgar.xml · nonDerivative · entry 1 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 48,549 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on March 10, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 21:02 UTC |
Balachandran MadhavanDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $8.49 | $0.00 |
DisclosureSEC source: 0000904454-26-000366 · edgar.xml · derivative · entry 3 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 10,000 shares Expires 2027-09-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on March 10, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · derivative.exercise_date: The Stock Option vested in full on September 20, 2021. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 21:02 UTC |
Balachandran MadhavanDirector
|
SaleOrdinary Shares | 10,000 | $27.85 | $278,500.00 |
DisclosureSEC source: 0000904454-26-000366 · edgar.xml · nonDerivative · entry 2 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,254 F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on March 10, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.58 to $28.05. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 21:02 UTC |
Balachandran MadhavanDirector
|
Exercise / conversionOrdinary Shares | 10,000 | $8.49 | $84,900.00 |
DisclosureSEC source: 0000904454-26-000366 · edgar.xml · nonDerivative · entry 1 Balachandran Madhavan · CIK 0001555508 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,254 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on March 10, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 20:56 UTC |
Potts JeannetteChief Legal Officer
|
SaleOrdinary Shares | 5,237 | $27.67 | $144,907.79 |
DisclosureSEC source: 0000904454-26-000364 · edgar.xml · nonDerivative · entry 1 Potts Jeannette · CIK 0001814693 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,246 F1 · kind: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F1 · shares: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.62 to $27.78. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 11, 2026 Filed Jun 12, 2026 21:38 UTC |
POST LEONARD EDirector
|
SaleOrdinary Shares | 1,993 | $27.06 | $53,930.58 |
DisclosureSEC source: 0000904454-26-000344 · edgar.xml · nonDerivative · entry 2 POST LEONARD E · CIK 0001235862 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,494 F2 · kind: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F2 · shares: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.92 to $27.25. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 11, 2026 Filed Jun 12, 2026 21:30 UTC |
Kaye JackDirector
|
SaleOrdinary Shares | 1,993 | $27.06 | $53,930.58 |
DisclosureSEC source: 0000904454-26-000342 · edgar.xml · nonDerivative · entry 2 Kaye Jack · CIK 0001376099 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,996 F2 · kind: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F2 · shares: The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.92 to $27.25. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.